How flexible is tipranavir in complex with the HIV-1 protease active site?

被引：6
|
作者：
不详
机构：
来源：
AIDS | 2004年 / 18卷 / 03期
关键词：
D O I：
10.1097/01.aids.0000111429.91384.be
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：579 / 580
页数：2
相关论文
共 50 条
  • [31] Non-active site mutations play a major role in HIV-1 protease drug resistance
    Muzammil, S
    Ross, P
    Freire, E
    FASEB JOURNAL, 2003, 17 (05): : A1330 - A1330
  • [32] Loss of the Protease Dimerization Inhibition Activity of Tipranavir (TPV) and Its Association with the Acquisition of Resistance to TPV by HIV-1
    Aoki, Manabu
    Danish, Matthew L.
    Aoki-Ogata, Hiromi
    Amano, Masayuki
    Ide, Kazuhiko
    Das, Debananda
    Koh, Yasuhiro
    Mitsuya, Hiroaki
    JOURNAL OF VIROLOGY, 2012, 86 (24) : 13384 - 13396
  • [33] How Does Darunavir Prevent HIV-1 Protease Dimerization?
    Huang, Danzhi
    Caflisch, Amedeo
    JOURNAL OF CHEMICAL THEORY AND COMPUTATION, 2012, 8 (05) : 1786 - 1794
  • [34] Impact of HIV-1 subtype in selecting mutations associated with response to boosted tipranavir in HIV-1-infected protease inhibitor experienced patients
    Flandre, P.
    Marcelin, A. G.
    Masquelier, B.
    Descamps, D.
    Izopet, J.
    Charpentier, C.
    Aloui, C.
    Peytavin, G.
    Lavignon, M.
    Calvez, V.
    ANTIVIRAL THERAPY, 2007, 12 : S83 - S83
  • [35] Tipranavir resistance associated mutations in protease inhibitor-naive patients with HIV-1 subtype A/E infection
    Sungkanuparph, Somnuek
    Sukasem, Chonlaphat
    Manosuthi, Weerawat
    Wiboonchutikul, Surasak
    Piyavong, Bucha
    Chantratita, Wasun
    JOURNAL OF CLINICAL VIROLOGY, 2008, 43 (03) : 284 - 286
  • [36] CRYSTALLIZATION OF HIV-1 PROTEASE IN THE COMPLEX WITH PEPTIDOMIMETIC INHIBITORS.
    Jerabkova, H.
    Hasek, J.
    Brynda, J.
    Hradilek, M.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 1999, 55 : 317 - 317
  • [37] Impact of HIV-1 subtype in selecting mutations associated with response to boosted tipranavir in HIV-1-infected protease inhibitor experienced patients
    Flandre, P.
    Marcelin, A. G.
    Masquelier, B.
    Descamps, D.
    Izopet, J.
    Charpentier, C.
    Aloui, C.
    Peytavin, G.
    Lavignon, M.
    Calvez, V.
    ANTIVIRAL THERAPY, 2007, 12 (05) : S83 - S83
  • [38] The Application of Deep Learning in the Prediction of HIV-1 Protease Cleavage Site
    Lu, Xinyu
    Wang, Lifang
    Jiang, Zejun
    2018 5TH INTERNATIONAL CONFERENCE ON SYSTEMS AND INFORMATICS (ICSAI), 2018, : 1299 - 1304
  • [39] Support vector machines for HIV-1 protease cleavage site prediction
    Nanni, L
    Lumini, A
    PATTERN RECOGNITION AND IMAGE ANALYSIS, PT 2, PROCEEDINGS, 2005, 3523 : 413 - 420
  • [40] Specificity rule discovery in HIV-1 protease cleavage site analysis
    Kim, Hyeoncheol
    Zhang, Yiying
    Heo, Yong-Seok
    Oh, Heung-Bum
    Chen, Su-Shing
    COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2008, 32 (01) : 72 - 79
12345